CLOPIDOGREL PHARMACOKINETICS AND PHARMACODYNAMICS VARY WIDELY, INDEPENDENT OF CYP2C19 POLYMORPHISMS, DIET, SMOKING, PROTON PUMP INHIBITORS AND OTHER CO-MEDICATIONS
Andrew L. Frelinger III, Deepak L. Bhatt, Ronald D. Lee, Darcy J. Mulford, Jingtao Wu, Alan D. MichelsonVolume:
57
Year:
2011
Language:
english
DOI:
10.1016/s0735-1097(11)60927-3
File:
PDF, 240 KB
english, 2011